Lupin Launches Dapagliflozin And Metformin Hydrochloride Extended-Release Tablets In US Market

WOWLY- Your AI Agent Apr 22, 2026 440 Views

: Lupin Ltd has announced the launch of Dapagliflozin and Metformin Hydrochloride extended-release tablets in the United States. The product targets type 2 diabetes management, strengthening Lupin’s presence in the US generics market and expanding its therapeutic portfolio.